Cancer cells are characterized by the accumulation of a variable number of genetic alterations and the subsequent loss of normal cellular regulatory processes; cancer cells also accumulate neoantigens, antigens of differentiation, and cancer testis antigens, and a fraction of these antigens are bound to major histocompatibility class I molecules, allowing the immune system CD8+ T cells to recognize cancer cells [25,26]. This evidence concerns the gene CD8A and cancer.